Catalent Supports Eli Lilly's Growing Global Clinical Trials Needs with New Investment in Automated Packaging Solutions

Catalent Supports Eli Lilly's Growing Global Clinical Trials Needs with New Investment in Automated Packaging Solutions

Posted:

This article was originally distributed via PRWeb. PRWeb, WorldNow and this Site make no warranties or representations in connection therewith.

SOURCE:

Catalent, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced that in support of its strategic partner, Eli Lillys growth, it is to install new automated prefilled syringe clinical packaging lines at its Philadelphia Clinical Supply Center of Excellence.

Somerset, N.J. (PRWEB) September 02, 2014

Catalent, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced that in support of its strategic partner, Eli Lillys growth, it is to install new automated prefilled syringe clinical packaging lines at its Philadelphia Clinical Supply Center of Excellence.

Catalent already has automated prefilled syringe packaging capabilities in its clinical supply facility in Schorndorf, Germany, providing end-to-end clinical supply solutions from clinical supply management, comparator sourcing and primary packaging to storage and distribution globally.

The packaging line is capable of the fully automated insertion of plunger rods, application of randomized and non-randomized labels and back-stop clips, and off-line labeling with booklet labels. This investment reflects a strong commitment from both Catalent and Eli Lilly to continue shared growth strategies, risks, and to build a long term strategic partnership.

Our continued investments in clinical packaging, cold chain storage, digital solutions, and our expansion into China are all part of our growth strategy and commitment to our customers to help them reduce clinical trial timelines, commented Gerry Hepburn, Chief Operating Officer, Vice President and General Manager of Catalents Clinical Supply Services business. Our strategic partnership with Eli Lilly supports their innovation by bringing more products faster to market.

For more information on Catalents Clinical Supply services, please visit: http://www.catalent.com/index.php/offerings/A-Z-Offerings/clinical-overview/clinical-supply-services

About Catalent

Catalent is the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products. With over 80 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable clinical and commercial product supply. Catalent employs approximately 8,000 people, including over 1,000 scientists, at 27 facilities across 5 continents. Catalent is headquartered in Somerset, N.J. For more information, visit http://www.catalent.com

More products. Better treatments. Reliably supplied.

For the original version on PRWeb visit: http://www.prweb.com/releases/2014/09/prweb12136471.htm

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact pressreleases@worldnow.com.